against CD28 or CD152

Industry

CPC
C07K16/2818

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K16/00Immunoglobulins [IGs]

Current Industry

C07K16/2818against CD28 or CD152

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
CD80 extracellular domain polypeptides and their use in cancer trea...
- Patent number 12,365,719
- Issue date Jul 22, 2025
- Five Prime Therapeutics, Inc.
- Thomas Brennan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DLL3 single domain antibodies and therapeutic compositions thereof
- Patent number 12,365,728
- Issue date Jul 22, 2025
- Inhibrx Biosciences, Inc.
- Brendan P. Eckelman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions of a PD-1 antibody and use of the same
- Patent number 12,364,756
- Issue date Jul 22, 2025
- MacroGenics, Inc.
- Krishnan Sampathkumar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nectin-4 antibody conjugates and uses thereof
- Patent number 12,364,768
- Issue date Jul 22, 2025
- ARARIS BIOTECH AG
- Peter R. Baum
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD28 x anti-PSMA antibodies
- Patent number 12,365,743
- Issue date Jul 22, 2025
- Xencor, Inc.
- John R. Desjarlais
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD8 binding agents
- Patent number 12,364,753
- Issue date Jul 22, 2025
- Orionis Biosciences BV
- Nikolai Kley
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Heterodimeric antibodies that bind CD3 and tumor antigens
- Patent number 12,359,002
- Issue date Jul 15, 2025
- Xencor, Inc.
- Matthew Bernett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies specifically binding to CD147 and uses thereof
- Patent number 12,357,691
- Issue date Jul 15, 2025
- Alphelix Biotech Co., Ltd.
- Xiangai Zhou
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
B-cell immunotherapy in cancer treatment
- Patent number 12,357,699
- Issue date Jul 15, 2025
- Alyssum Therapeutic s, Inc.
- Shiladitya Sengupta
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cancer by targeting cold tumors
- Patent number 12,357,633
- Issue date Jul 15, 2025
- Celgene Corporation
- Ellen Filvaroff
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocki...
- Patent number 12,358,986
- Issue date Jul 15, 2025
- Merck Sharp & Dohme LLC
- Drake LaFace
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-modified chimeric antigen receptor modified T cell and use...
- Patent number 12,358,994
- Issue date Jul 15, 2025
- Shanghai Cell Therapy Group Co., Ltd.
- Qijun Qian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-CD47/anti-PD-1 bispecific antibody, preparation method and use...
- Patent number 12,358,987
- Issue date Jul 15, 2025
- Nanjing GenScript Biotech Co., Ltd.
- Liusong Yin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered immunostimulatory bacterial strains and uses thereof
- Patent number 12,357,661
- Issue date Jul 15, 2025
- Actym Therapeutics, Inc.
- Christopher D. Thanos
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating cancer with anti-PD-1 antibodies
- Patent number 12,358,984
- Issue date Jul 15, 2025
- Merck Sharp & Dohme LLC
- Mallika Lala
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-B7S1 polypeptides and their use
- Patent number 12,358,985
- Issue date Jul 15, 2025
- SUZHOU KANOVA BIOPHARMACEUTICAL CO., LTD.
- Li Guo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunomodulating polynucleotides, antibody conjugates thereof, and...
- Patent number 12,351,598
- Issue date Jul 8, 2025
- TALLAC THERAPEUTICS, INC.
- Sukumar Sakamuri
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant oncolytic virus composition and use thereof
- Patent number 12,350,304
- Issue date Jul 8, 2025
- BEIJING WELLGENE COMPANY LTD.
- Chao Tian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for immune-mediated cancer therapy
- Patent number 12,350,275
- Issue date Jul 8, 2025
- TECLISON, INC.
- Ruey-min Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Programmable bacteria for the treatment of cancer
- Patent number 12,350,297
- Issue date Jul 8, 2025
- The Trustees of Columbia University In the City of New York
- Tal Danino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD1 and/or LAG3 binders
- Patent number 12,351,630
- Issue date Jul 8, 2025
- Merck Sharp & Dohme LLC
- Edward Bowman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion immunomodulatory proteins and methods for making same
- Patent number 12,351,636
- Issue date Jul 8, 2025
- Biocon Ltd.
- Nagaraj Govindappa
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gamma polyglutamated aminopterin and uses thereof
- Patent number 12,350,271
- Issue date Jul 8, 2025
- L.E.A.F. Holdings Group LLC
- Clet Niyikiza
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Checkpoint regulator antagonists
- Patent number 12,350,333
- Issue date Jul 8, 2025
- Gensun Biopharma Inc.
- Jackie Z. Sheng
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ILT4 antibodies and antigen-binding fragments
- Patent number 12,344,670
- Issue date Jul 1, 2025
- Agenus Inc.
- Milan Blanusa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Immunoreactant carrier
- Patent number 12,343,406
- Issue date Jul 1, 2025
- LEMONEX INC.
- Cheol Hee Won
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-2 superagonists in combination with anti-PD-1 antibodies
- Patent number 12,338,269
- Issue date Jun 24, 2025
- Medicenna Therapeutics Inc.
- Fahar Merchant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-1/Pd-L1 inhibitors
- Patent number 12,338,233
- Issue date Jun 24, 2025
- Gilead Sciences, Inc.
- Evangelos Aktoudianakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for targeting the immune checkpoint PD1 pathway for treatin...
- Patent number 12,338,283
- Issue date Jun 24, 2025
- Cedars-Sinai Medical Center
- Paul W. Noble
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody variant combinations and uses thereof
- Patent number 12,338,289
- Issue date Jun 24, 2025
- GENMAB B.V.
- Rob De Jong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
- Publication number 20250236650
- Publication date Jul 24, 2025
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A COMBINATION OF IMMUNOMODULATION AND CHE...
- Publication number 20250235546
- Publication date Jul 24, 2025
- ANGIMMUNE, LLC
- David M. Neville
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING...
- Publication number 20250236889
- Publication date Jul 24, 2025
- Exuma Biotech Corp.
- Gregory Ian FROST
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHARMACEUTICAL COMPOSITION OF ANTI-TIM-3 ANTIBODY AND HYPOMETHYLATI...
- Publication number 20250230242
- Publication date Jul 17, 2025
- NANJING SHUNXIN PHARMACEUTICALS CO., LTD. OF CHIATAI TIANQING PHARM. GROUP
- Zaizhi GUI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREDICTION OF CHEMOTHERAPY-FREE IMMUNOTHERAPY EFFECTIVENESS FOR PAT...
- Publication number 20250230243
- Publication date Jul 17, 2025
- Foundation Medicine, Inc.
- Ryon P. GRAF
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-CD39 NANOBODY AND USES THEREOF
- Publication number 20250230255
- Publication date Jul 17, 2025
- BIOTHEUS INC.
- Zhenqing ZHANG
- G01 - MEASURING TESTING
Information Patent Application
Methods and Products to Screen and Treat Glioblastoma Multiforme an...
- Publication number 20250228863
- Publication date Jul 17, 2025
- GLOBAL CANCER TECHNOLOGY, INC.
- Martha Karen Newell ROGERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fusion Molecules Of CTLA4 And IL-15
- Publication number 20250230211
- Publication date Jul 17, 2025
- NANTCELL, INC.
- Clifford Anders Olson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-TIGIT-ANTI-PVRIG BISPECIFIC ANTIBODY, PHARMACEUTICAL COMPOSITI...
- Publication number 20250223354
- Publication date Jul 10, 2025
- BIOTHEUS INC.
- Tianhang ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BI-SPECIFIC ANTIBODIES AGAINST TIM-3 AND PD-1 FOR IMMUNOTHERAPY IN...
- Publication number 20250223357
- Publication date Jul 10, 2025
- The Brigham & Women's Hospital, Inc.
- Vijay K. Kuchroo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOMODULATING TREATMENTS OF BODY CAVITIES
- Publication number 20250221929
- Publication date Jul 10, 2025
- UROGEN PHARMA LTD
- Caretha L. Creasy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY INVOLVING ANTI-HLA-G ANTIBODIES AND ANTI-EGFR A...
- Publication number 20250223363
- Publication date Jul 10, 2025
- TIZONA THERAPEUTICS, INC.
- Courtney Beers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FGFR2 INHIBITORS ALONE OR IN COMBINATION WITH IMMUNE STIMULATING AG...
- Publication number 20250223367
- Publication date Jul 10, 2025
- Five Prime Therapeutics, Inc.
- Kristen Pierce
- G01 - MEASURING TESTING
Information Patent Application
BISPECIFIC ANTI-CD28 X ANTI-CD22 ANTIBODIES AND USES THEREOF
- Publication number 20250223360
- Publication date Jul 10, 2025
- Regeneron Pharmaceuticals, Inc.
- Andrew J. Murphy
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-PVRIG ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THE...
- Publication number 20250223353
- Publication date Jul 10, 2025
- BIOTHEUS INC.
- Tianhang ZHAI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MRNAS ENCODING CHECKPOINT CANCER VACCINES AND USES THEREOF
- Publication number 20250213664
- Publication date Jul 3, 2025
- ModernaTX, Inc.
- Joshua P. Frederick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF
- Publication number 20250215072
- Publication date Jul 3, 2025
- Scholar Rock, Inc.
- Abhishek Datta
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-PD-1 ANTIBODY FORMULATIONS
- Publication number 20250215086
- Publication date Jul 3, 2025
- Amgen Inc.
- Shantanu Sule
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR THE TREATMENT OF CANCER
- Publication number 20250215088
- Publication date Jul 3, 2025
- TERSESA THERAPEUTICS LLC
- Jon Marc Wigginton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD28/OX40 BISPECIFIC ANTIBODIES
- Publication number 20250215102
- Publication date Jul 3, 2025
- SANOFI
- Gerald BESTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF
- Publication number 20250213476
- Publication date Jul 3, 2025
- L.E.A.F. HOLDINGS GROUP LLC
- Clet NIYIKIZA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER WITH L...
- Publication number 20250215112
- Publication date Jul 3, 2025
- Yuhan Corporation
- Eunjung LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA
- Publication number 20250215076
- Publication date Jul 3, 2025
- Bristol-Myers Squibb Company
- Rebecca Anne MOSS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Adenoviral Mediated Targeting of Activated Immune Cells
- Publication number 20250215452
- Publication date Jul 3, 2025
- Universitat Zurich
- Patrick Christian FREITAG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT
- Publication number 20250215087
- Publication date Jul 3, 2025
- Bristol-Myers Squibb Company
- David Julian Harry DOWNWARD
- G01 - MEASURING TESTING
Information Patent Application
ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
- Publication number 20250215108
- Publication date Jul 3, 2025
- OSE IMMUNOTHERAPEUTICS
- Nicolas POIRIER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES
- Publication number 20250213724
- Publication date Jul 3, 2025
- CureVac SE
- Mariola FOTIN-MLECZEK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANIMAL MODEL GENERATING HUMANIZED ANTIBODY AND CONSTRUCTION METHOD...
- Publication number 20250212857
- Publication date Jul 3, 2025
- GEMPHARMATECH CO., LTD.
- Mingkun ZHANG
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION
- Publication number 20250213681
- Publication date Jul 3, 2025
- OnkosXcel Therapeutics, LLC
- Luca RASTELLI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND T...
- Publication number 20250215079
- Publication date Jul 3, 2025
- JANSSEN BIOTECH, INC.
- Raluca Verona
- C07 - ORGANIC CHEMISTRY

against CD28 or CD152

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

CD80 extracellular domain polypeptides and their use in cancer trea...

DLL3 single domain antibodies and therapeutic compositions thereof

Pharmaceutical compositions of a PD-1 antibody and use of the same

Nectin-4 antibody conjugates and uses thereof

Anti-CD28 x anti-PSMA antibodies

CD8 binding agents

Heterodimeric antibodies that bind CD3 and tumor antigens

Antibodies specifically binding to CD147 and uses thereof

B-cell immunotherapy in cancer treatment

Methods of treating cancer by targeting cold tumors

Anti-cancer combination therapies comprising CTLA-4 and PD-1 blocki...

Antibody-modified chimeric antigen receptor modified T cell and use...

Anti-CD47/anti-PD-1 bispecific antibody, preparation method and use...

Engineered immunostimulatory bacterial strains and uses thereof

Methods for treating cancer with anti-PD-1 antibodies

Anti-B7S1 polypeptides and their use

Immunomodulating polynucleotides, antibody conjugates thereof, and...

Recombinant oncolytic virus composition and use thereof

Compositions and methods for immune-mediated cancer therapy

Programmable bacteria for the treatment of cancer

PD1 and/or LAG3 binders

Fusion immunomodulatory proteins and methods for making same

Gamma polyglutamated aminopterin and uses thereof

Checkpoint regulator antagonists

Anti-ILT4 antibodies and antigen-binding fragments

Immunoreactant carrier

IL-2 superagonists in combination with anti-PD-1 antibodies

PD-1/Pd-L1 inhibitors

Methods for targeting the immune checkpoint PD1 pathway for treatin...

Antibody variant combinations and uses thereof

Patents Applicationslast 30 patents

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

TREATMENT OF CANCER USING A COMBINATION OF IMMUNOMODULATION AND CHE...

METHODS AND COMPOSITIONS FOR TRANSDUCING LYMPHOCYTES AND REGULATING...

PHARMACEUTICAL COMPOSITION OF ANTI-TIM-3 ANTIBODY AND HYPOMETHYLATI...

PREDICTION OF CHEMOTHERAPY-FREE IMMUNOTHERAPY EFFECTIVENESS FOR PAT...

ANTI-CD39 NANOBODY AND USES THEREOF

Methods and Products to Screen and Treat Glioblastoma Multiforme an...

Fusion Molecules Of CTLA4 And IL-15

ANTI-TIGIT-ANTI-PVRIG BISPECIFIC ANTIBODY, PHARMACEUTICAL COMPOSITI...

BI-SPECIFIC ANTIBODIES AGAINST TIM-3 AND PD-1 FOR IMMUNOTHERAPY IN...

IMMUNOMODULATING TREATMENTS OF BODY CAVITIES

COMBINATION THERAPY INVOLVING ANTI-HLA-G ANTIBODIES AND ANTI-EGFR A...

FGFR2 INHIBITORS ALONE OR IN COMBINATION WITH IMMUNE STIMULATING AG...

BISPECIFIC ANTI-CD28 X ANTI-CD22 ANTIBODIES AND USES THEREOF

ANTI-PVRIG ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THE...

MRNAS ENCODING CHECKPOINT CANCER VACCINES AND USES THEREOF

ISOFORM-SELECTIVE TGFB1 INHIBITORS AND USE THEREOF

ANTI-PD-1 ANTIBODY FORMULATIONS

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

CD28/OX40 BISPECIFIC ANTIBODIES

GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER WITH L...

COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA

Adenoviral Mediated Targeting of Activated Immune Cells

COMBINATION THERAPY OF KRAS INHIBITOR AND TREG DEPLETING AGENT

ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

RNA CONTAINING COMPOSITION FOR TREATMENT OF TUMOR DISEASES

ANIMAL MODEL GENERATING HUMANIZED ANTIBODY AND CONSTRUCTION METHOD...

NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION

ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND T...